Multicenter Study of the Hemorrhage Risk after Endoscopic Mucosal Resection Associated with Direct Oral Anticoagulants
Table 1
Clinical characteristics of patients receiving endoscopic mucosal resection in the DOAC, warfarin, antiplatelet, and no antithrombotics groups.
Total
DOAC group
Warfarin group
Antiplatelet group
No antithrombotics group
Case number
2062
63
34
185
1780
Age (years), (range, min-max)
(20-93)
(57-88)
(52-86)
(41-93)
(20-93)
Sex: M/F (% ())
63.2/36.8 (1304/758)
66.7/33.3 (42/21)
67.6/32.4 (23/11)
75.1/24.9 (139/46)
61.8/38.2 (1100/680)
Mean polyp size (mm), (range, min-max)
(3-30)
(3-30)
(3-20)
(3-18)
(3-18)
Rate of right-sided colon (%)
51.8 (132/255)
48.1 (65/135)
41.2 (7/17)
48.1 (25/52)
68.6 (35/51)
Coprescription of antiplatelet (%())
N/A
17.5 (11)
23.5 (8)
N/A
N/A
vs. no antithrombotics group: . DOAC: direct oral anticoagulant; M: male; F: female; min: minimum; max: maximum; right-sided: cecum to transverse colon; N/A: not applicable.
